Premium
New report examines medication trends for depression, anxiety and insomnia
Author(s) -
Canady Valerie A.
Publication year - 2020
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.32344
Subject(s) - anxiety , insomnia , depression (economics) , medical prescription , pharmacy , covid-19 , antidepressant , psychiatry , medicine , psychology , family medicine , pharmacology , disease , infectious disease (medical specialty) , economics , macroeconomics
As COVID‐19 continues to significantly impact the United States from a physical, mental and financial standpoint, an early analysis by a pharmacy benefit management organization of filled prescriptions at the onset of COVID‐19 has found increases in the use of anti‐anxiety and antidepressant medications.